U.S. Markets open in 51 hrs, 23 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 27.88 03:27 PM EDT | |
|---|---|---|
| Day High | 28.90 09:32 AM EDT |
|
| Range | 1.02 |
| Volume | 507,145 | |
|---|---|---|
| 30-Day Avg Vol | 782,000 |
|
| Difference | -35.15% |
| Market Cap | 1.59 B | |
|---|---|---|
| Mkt Cap Chg | -48.35 M |
| Shares Out | 56.88 M | |
|---|---|---|
| % Shrs Traded | 0.89% | |
| 1yr EPS Est | 0.89 |
| 52-Wk Low | 21.66 10/28/08 | |
|---|---|---|
| 52-Wk High | 45.69 8/18/08 |
|
| Range | 24.03 |
| Prev Close | 28.82 7/1/09 | |
|---|---|---|
| Today's Open | 28.60 | |
| Change | -0.76% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 4.07 M |
| Revenue (LFY) | 194.34 M | |
|---|---|---|
| Earnings (LFY) | 1.95 M | |
| Earnings (MRQ) | 4.06 M | |
| Next Earn Est | 0.14 | |
| Next Earnings | 08/13/2009 |
|
| EPS (TTM) | -0.17 | |
| 1yr EPS Growth | 623.53% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | 31.00 | |
| PEG Ratio | 1.03 | |
| Return on Equity | -10.58 | |
| Beta | 0.61 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Onyx Pharmaceuticals' cancer drug could turn out to be a real gem. Working with health care behemoth Bayer, the biotechnology company developed Nexavar, an FDA-approved treatment for advanced kidney cancer ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.14 8/5/09 | — — |
—
—
|
| Last Quarter | 0.165 3/31/09 | 0.07 3/31/09 |
-0.095
Missed
|
| 2 Quarters Ago | -0.591 12/31/08 | -0.53 12/31/08 |
0.061
Beat
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 53.72 M | 194.34 M |
| Gross Profit | -8.58 M | 193.01 M |
| Operating Income | 2.94 M | -10.40 M |
| Net Income | 4.06 M | 1.95 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts